2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
CNS
6
Genitourinary
3
Other
2
Lymphoid
2
Thoracic
1
Head & Neck
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Prostatic Neoplasms
6268
Carcinoma, Renal Cell
1913
Urinary Bladder Neoplasms
1670
Kidney Neoplasms
930
Breast Neoplasms
793
Neoplasms
788
Carcinoma, Transitional Cell
592
Carcinoma, Non-Small-Cell Lung
524
Neoplasm Metastasis
510
Melanoma
484
Ovarian Neoplasms
468
Colorectal Neoplasms
454
Lung Neoplasms
435
Pancreatic Neoplasms
325
Testicular Neoplasms
290
Stomach Neoplasms
274
Sarcoma
266
Uterine Cervical Neoplasms
264
Non-Muscle Invasive Bladder Neoplasms
263
Head and Neck Neoplasms
241
Colonic Neoplasms
217
Esophageal Neoplasms
203
Squamous Cell Carcinoma of Head and Neck
202
Carcinoma, Hepatocellular
197
Wilms Tumor
196
Endometrial Neoplasms
189
Recurrence
162
Neuroblastoma
148
Urologic Neoplasms
147
Small Cell Lung Carcinoma
146
Interventions
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Ischemic Stroke
×
Genitourinary
×
Clear all
NCT03987633
2025-03-10
EMPOWER
Future Genetics Limited
Recruiting
200,000 enrolled
NCT02626377
2023-10-23
ICE
Centre Hospitalier Universitaire de Besancon
Phase NA
Terminated
186 enrolled
NCT02895230
2023-08-01
ADTCR
Rennes University Hospital
Completed
38,690 enrolled